Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Innovaccer Lands USD 275M to Fuel Healthcare AI Revolution

Morepen Labs receives board approval to raise up to Rs 350 crore

Ruchika Sharma24 Feb 2024 12:30 PM IST

New Delhi: Morepen Laboratories on Thursday said its board has approved to raise up to Rs 350 crore via issue of securities.The company's board...

Unichem Labs Roha facility gets 3 USFDA observations

USFDA completes inspections at Suven Pharma facilities with no form 483

Ruchika Sharma24 Feb 2024 11:45 AM IST

Hyderabad: Suven Pharma has announced that the US Food & Drug Administration (US FDA) has completed the inspections at the Company's...

Sanofi gets USFDA fast track designation for neovascular age-related macular degeneration gene therapy

Dupixent application accepted for priority review by USFDA for COPD with type 2 inflammation

Ruchika Sharma23 Feb 2024 4:30 PM IST

Paris: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License...

Bayer begins Phase II study with anti-alpha2 antiplasmin antibody in patients with deep vein thrombosis

Ruchika Sharma23 Feb 2024 2:30 PM IST

Berlin: Bayer has announced the start of a Phase II clinical trial (SIRIUS study) with BAY3018250, an investigational first-in-class anti-alpha2...

Insufficient Efficacy, Safety Data: CDSCO Panel Rejects Zydus Phase III CT Waiver Request for Voclosporin

Zydus Lifesciences incorporates wholly owned subsidiary company in UAE

Ruchika Sharma23 Feb 2024 1:30 PM IST

Ahmedabad: Zydus Lifesciences has incorporated a wholly owned subsidiary company in the name of Zydus Lifesciences Global FZE. in Jebel...

Royalty Pharma to buy royalty interest in Amgen Imdelltra for up to USD 950 million

AstraZeneca completes acquisition of Gracell Biotechnologies

Ruchika Sharma23 Feb 2024 12:30 PM IST

Gracell will operate as a wholly owned subsidiary of AstraZeneca, with operations in China and the US.

Novavax settles dispute with Gavi

Ruchika Sharma23 Feb 2024 11:30 AM IST

Novavax has agreed to pay back international vaccine group Gavi at least $475 million in cash or vaccines by the end of 2028, settling a dispute over...

Cipla inks pacts to invest in iCaltech Innovations

Cipla, Dr Reddys and other Indian Pharma companies now in race to develop Wegovy versions

Ruchika Sharma22 Feb 2024 2:27 PM IST

"Dr Reddy's and Cipla are making a copy of the innovator drug more like a generic version, while Sun is working on its own innovator drug. So, Sun...

Bristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab brengitecan for previously treated Advanced EGFR Mutated Non Small Cell Lung Cancer

USFDA accepts for priority review Bristol Myers Squibb application for Krazati, cetuximab combo for colorectal cancer

Ruchika Sharma22 Feb 2024 1:30 PM IST

New York: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the supplemental...

AbbVie seeks USFDA nod for combination regimen of Venclexta, Acalabrutinib

Merck application for Keytruda plus chemotherapy for Primary Advanced or Recurrent Endometrial Carcinoma accepted by USFDA for priority review

Ruchika Sharma22 Feb 2024 12:30 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...

Novartis, Argo Biopharma expand strategic alliance with USD 5.2 billion Cardiovascular drugs deal

Britain health regulator revokes conditional marketing authorisation for Novartis sickle cell drug Adakveo

Ruchika Sharma22 Feb 2024 11:20 AM IST

Sickle cell disease is a genetic disorder in which misshapen blood cells cause strokes, organ damage, severe pain and early death.

Medtronic gets USFDA nod for OmniaSecure defibrillation lead for placement within right ventricle

Medtronic raises annual profit forecast on strong demand for heart devices

Ruchika Sharma22 Feb 2024 9:00 AM IST

Medtronic also said it has decided to exit its unprofitable ventilator product line within its patient monitoring and respiratory interventions...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok